GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Other Long-Term Liabilities

Laboratorio Farmaceutico Erfo SpA (FRA:RK7) Other Long-Term Liabilities : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Other Long-Term Liabilities?

Laboratorio Farmaceutico Erfo SpA's other long-term liabilities for the quarter that ended in Dec. 2024 was €0.00 Mil.

Laboratorio Farmaceutico Erfo SpA's quarterly other long-term liabilities declined from Dec. 2023 (€9.48 Mil) to Jun. 2024 (€0.00 Mil) but then increased from Jun. 2024 (€0.00 Mil) to Dec. 2024 (€0.00 Mil).

Laboratorio Farmaceutico Erfo SpA's annual other long-term liabilities declined from Dec. 2022 (€9.82 Mil) to Dec. 2023 (€9.48 Mil) and declined from Dec. 2023 (€9.48 Mil) to Dec. 2024 (€0.00 Mil).

Laboratorio Farmaceutico Erfo SpA Other Long-Term Liabilities Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Other Long-Term Liabilities Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long-Term Liabilities
Get a 7-Day Free Trial - - 9.82 9.48 -

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.82 0.02 9.48 - -

Laboratorio Farmaceutico Erfo SpA Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Laboratorio Farmaceutico Erfo SpA Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Farmaceutico Erfo SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Other Long-Term Liabilities
Comparable Companies
MIL:CLI XSWX:NESN XPAR:BN SHSE:603288 KHC GIS K NSE:NESTLEIND SHSE:600887 TSE:2802 SZSE:300999 LSE:ABF MKC DUB:KRZ BSP:JBSS3 HRL BOM:500825 TPE:1216 SGX:F34 BOG:NUTRESA
Traded in Other Exchanges
ERFO:Italy
Address
Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Website
https://www.erfo.it
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines